Dr. Rangaswamy Govindarajan
Claim this profileJohn L McClellan Memorial Veterans Hospital
Studies Lung Cancer
Studies Prostate Cancer
10 reported clinical trials
42 drugs studied
Area of expertise
1Lung Cancer
Stage IV
ALK positive
Stage I
2Prostate Cancer
Stage IV
Affiliated Hospitals
Clinical Trials Rangaswamy Govindarajan is currently running
Nivolumab + Standard Treatment
for Stomach and Esophageal Cancer
This phase II/III trial compares the addition of nivolumab to the usual treatment of paclitaxel and ramucirumab to paclitaxel and ramucirumab alone in treating patients with gastric or esophageal adenocarcinoma that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Paclitaxel is in a class of medications called antimicrotubule agents. It stops cancer cells from growing and dividing and may kill them. Adding nivolumab to ramucirumab and paclitaxel may work better to treat patients with advanced stomach or esophageal cancer.
Recruiting1 award Phase 2 & 320 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Rangaswamy Govindarajan
Clinical Trial Related7 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Rangaswamy Govindarajan has experience with
- Crizotinib
- Abiraterone Acetate
- Cabazitaxel
- Antiandrogen Therapy
- Prednisone
- Ulixertinib
Breakdown of trials Rangaswamy Govindarajan has run
Lung Cancer
Prostate Cancer
Colorectal Cancer
Esophageal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rangaswamy Govindarajan specialize in?
Rangaswamy Govindarajan focuses on Lung Cancer and Prostate Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are ALK positive.
Is Rangaswamy Govindarajan currently recruiting for clinical trials?
Yes, Rangaswamy Govindarajan is currently recruiting for 4 clinical trials in Little Rock Arkansas. If you're interested in participating, you should apply.
Are there any treatments that Rangaswamy Govindarajan has studied deeply?
Yes, Rangaswamy Govindarajan has studied treatments such as Crizotinib, Abiraterone Acetate, Cabazitaxel.
What is the best way to schedule an appointment with Rangaswamy Govindarajan?
Apply for one of the trials that Rangaswamy Govindarajan is conducting.
What is the office address of Rangaswamy Govindarajan?
The office of Rangaswamy Govindarajan is located at: John L McClellan Memorial Veterans Hospital, Little Rock, Arkansas 72205 United States. This is the address for their practice at the John L McClellan Memorial Veterans Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.